论文部分内容阅读
目的:探讨CRP在乳腺癌临床诊断与疗效评价中的意义。方法:采用免疫比浊法测定乳腺癌患者治疗前后血清CRP的含量。结果:T0-T1分期乳腺癌患者治疗前血清中CRP平均水平(4.6±1.6)mg/L,治疗后预后良好者血清中CRP浓度呈下降趋势,预后不良者呈波动上升。结论:动态观察血清CRP水平对乳腺癌的疗效观察有一定的临床意义。
Objective: To investigate the significance of CRP in clinical diagnosis and evaluation of breast cancer. Methods: The levels of serum CRP in breast cancer patients before and after treatment were measured by immunoturbidimetry. Results: The average level of CRP in pretreatment serum of T0-T1 stage breast cancer patients was (4.6 ± 1.6) mg / L. The CRP levels in serum with a good prognosis decreased after treatment, while the patients with poor prognosis showed a fluctuant increase. Conclusion: The dynamic observation of serum CRP level has some clinical significance in the treatment of breast cancer.